Sign up
Quantellect · Congress · Trade Detail
NASDAQ: ALNYAlnylam Pharmaceuticals Inc
DemocratHouse

Daniel S. Goldman bought Alnylam Pharmaceuticals Inc (NASDAQ: ALNY)

Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 2 trades in Alnylam Pharmaceuticals Inc (ALNY) since 2023, 1 purchase and 1 sale, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Daniel S. Goldman bought $15,001 - $50,000 of Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) on March 6, 2023. Since that trade, ALNY is up +43.53% against the S&P 500 up +88.13%, an outperformance of -44.61%.

Across these filings, Daniel S. Goldman has been a balanced trader of ALNY (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ALNY trades
2
Disclosed Vol
$65K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2023

Daniel S. Goldman's ALNY trades vs the price

ALNY is up +43.53% since Daniel S. Goldman bought on March 6, 2023, versus +88.13% for the S&P 500.

Performance since this trade

Price change since trade
+43.53%
S&P 500 change since trade
+88.13%
Outperformance vs S&P 500
-44.61%

All Daniel S. Goldman ALNY trades

TradedTypeSizeReturnEst. profit
March 6, 2023BUY$199.70+43.53%+$14K
January 31, 2023SELL$226.40+26.60%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Daniel S. Goldman & ALNY trading FAQ

Is it legal for Daniel S. Goldman to trade Alnylam Pharmaceuticals Inc (ALNY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Alnylam Pharmaceuticals Inc (ALNY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Daniel S. Goldman buy ALNY?

Daniel S. Goldman disclosed a purchase of $15,001 - $50,000 of Alnylam Pharmaceuticals Inc (ALNY) on March 6, 2023, according to public STOCK Act filings.

How has ALNY performed since Daniel S. Goldman's trade?

Since Daniel S. Goldman bought ALNY on March 6, 2023, the stock is up +43.53%, versus +88.13% for the S&P 500 over the same period, an outperformance of -44.61%.

How many times has Daniel S. Goldman traded ALNY?

Daniel S. Goldman has disclosed 2 ALNY trades since 2023 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ALNY trades?

Quantellect tracks every disclosed congressional trade in Alnylam Pharmaceuticals Inc (ALNY) on the Alnylam Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Daniel S. Goldman's ALNY tradesAll congressional filings for Alnylam Pharmaceuticals IncDaniel S. Goldman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.